2019 annual financial data
Redhill Biopharma 2019 Operating cash flow margin
Direct answer
Operating cash flow margin was -647.73%.
Operating income was -43,201,000 USD and net income was -42,304,000 USD.
Operating cash flow was -40,749,000 USD.
Get free Redhill Biopharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 6,291,000 USD
- Operating income
- -43,201,000 USD
- Net income
- -42,304,000 USD
- Operating cash flow
- -40,749,000 USD